2013 – Foresight in medicine, Washington USA

Condividi su
Data dell'evento: 13/12/2013
symposiumUSA

December 13th, 2013
Symposium at the Embassy of Italy - Washington
"I Am Not My Body. I Am My Mind"
in memory of Rita Levi-Montalcini
Foresight in medicine: research induced society changes in the next decade

The symposium hosts a debate among scientists, doctors, policy makers and epistemologists aimed at identifying forthcoming medical research developments likely to impact on society in the next ten years.
Personalized (or precision) medicine is the changing paradigm and will reshape service contents and delivery modalities. The main clinical areas where major progress is expected are cancer, neurodegenerative disorders, chronic obstructive pulmonary diseases, rare diseases, dysmetabolic and endocrine system related diseases.
Progress in imaging, the application of nanotechnologies, the use of robotics, wired environments and telematics, portable devices, stem cells and new materials will make personalized medicine feasible and affordable. At the same time, epigenetics, pharmacogenomics, synthetic biology will contribute extensively to change further medicine and its social aspects, and will need to be regulated by a new bioethical approach.
Prof. Alessandro Vercelli, NICO, is one of panel members of Session 2:
Focal clinical areas where major progress is expected are cancer, neuro-degenerative disorders, chronic obstructive pulmonary diseases, rare diseases, dysmetabolic and endocrine system related diseases.
How science and technology will impact on diseases, their prevention, treatment, and rehabilitation?
What will be patients' life expectancy? Will there be an impact on survival quality? Will palliative care improve?
And how will the health systems cope with an ageing and fragile population?

Symposium program

Agenda

21 marzo 2019

NICO Progress Report - INN Open Neuroscience Forum 2019

I nostri giovani ricercatori aggiornano i colleghi sulle loro ricerche. Appuntamento ogni due venerdì.

Ricerca

Atassia: scoperto il difetto cellulare responsabile di una rara malattia neurologica

Un malfunzionamento dei mitocondri, le centrali energetiche delle cellule, causa lo sviluppo della SCA28, una forma ereditaria di atassia. Dopo 10 anni di studi e grazie al sostegno di Fondazione Telethon, la scoperta del team di ricerca guidato dai proff. Alfredo Brusco e Filippo Tempia dell’Università di Torino e NICO. Lo studio pubblicato sulla prestigiosa rivista Neurobiology of Disease.

4 dicembre 2018